About the journal
Frontiers in Drug Delivery is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 2674-0850
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,950 CHF
- Articles in DOAJ
- 99
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.frontiersin.org/journals/drug-delivery/
Index listings
- DOAJ · 2022-11-20
- Indexing
- DOAJ
- APC
- 1,950 CHF
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
99
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
124
Last recorded publication year
2026
h-index
17
i10-index
35
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2022-11-20
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 90%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918469589006676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Advanced Drug Delivery Systems
- Advanced Drug Delivery Systems
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Inhalation and Respiratory Drug Delivery
- Advancements in Transdermal Drug Delivery
- RNA Interference and Gene Delivery
Show all subjects (50)
- RNA Interference and Gene Delivery
- Advancements in Transdermal Drug Delivery
- Barrier Structure and Function Studies
- Barrier Structure and Function Studies
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- CRISPR and Genetic Engineering
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- CRISPR and Genetic Engineering
- 3D Printing in Biomedical Research
- Retinal Development and Disorders
- Extracellular vesicles in disease
- 3D Printing in Biomedical Research
- Immunotherapy and Immune Responses
- Extracellular vesicles in disease
- Retinal Development and Disorders
- Immunotherapy and Immune Responses
- Dermatology and Skin Diseases
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Dermatology and Skin Diseases
- Virus-based gene therapy research
- Virus-based gene therapy research
- Monoclonal and Polyclonal Antibodies Research
- Respiratory and Cough-Related Research
- Respiratory and Cough-Related Research
- Monoclonal and Polyclonal Antibodies Research
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Asthma and respiratory diseases
- Advanced biosensing and bioanalysis techniques
- Asthma and respiratory diseases
- Advanced biosensing and bioanalysis techniques
- Retinal Diseases and Treatments
- Cystic Fibrosis Research Advances
- Retinal Diseases and Treatments
- Influenza Virus Research Studies
- Influenza Virus Research Studies
- Neurogenesis and neuroplasticity mechanisms
- Cystic Fibrosis Research Advances
- Wound Healing and Treatments
Keywords (DOAJ)
- pharmacology
- basic pharmacology
- clinical pharmacology
- therapeutics
- opthalmology
- molecular targets
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ